aspirin has been researched along with 2,3-dinor-6-ketoprostaglandin f1alpha in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (30.43) | 18.7374 |
| 1990's | 8 (34.78) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawano, K; Kimura, B; Konno, S; Tamura, K; Tohgi, H | 1 |
| Catella, F; Fitzgerald, GA; Lupinetti, MD; Sheller, JR | 1 |
| Barrow, SE; Beacham, J; Cockcroft, JR; Doktor, HS; Ritter, JM | 1 |
| Boss, AH; Catella, F; Ciabattoni, G; Daffonchio, L; Daugherty, J; Dray, F; FitzGerald, GA; Patrono, C | 1 |
| Fischer, C; Frölich, JC; Meese, CO; Rosenkranz, B | 1 |
| Vesterqvist, O | 1 |
| Brash, A; Fitzgerald, G; Oates, JA | 1 |
| Gréen, K; Vesterqvist, O | 1 |
| Bode-Böger, SM; Böger, RH; Frölich, JC; Schröder, EP; Tsikas, D | 1 |
| Gréen, K; Henriksson, P; Rasmanis, G; Vesterqvist, O | 1 |
| Bachir, D; Foulon, I; Galacteros, F; Maclouf, J | 1 |
| Gullichsen, E; Kuttila, K; Mucha, I; Nelimarkka, O; Niinikoski, J; Rautanen, M; Riutta, A | 1 |
| Boylan, PC; Fitzgerald, DJ; FitzGerald, GA; McAdam, BF; McParland, P; Regan, CL | 1 |
| Guzzo, C; Lazarus, G; Mitchell, TA; Morrow, JD; Oates, JA; Roberts, LJ; Zackert, WE | 1 |
| Hishinuma, T; Matsumura, E; Mizugaki, M; Murai, Y; Tamai, M; Yamanobe, S; Yamazaki, T | 1 |
| Belton, O; Byrne, D; Fitzgerald, DJ; Kearney, D; Leahy, A | 1 |
| Adderley, SR; Cunningham, AJ; Dowd, NP; Fitzgerald, DJ; Scully, M | 1 |
| Capone, ML; Di Gregorio, P; Grana, M; Merciaro, G; Minuz, P; Patrignani, P; Patrono, C; Ricciotti, E; Sciulli, MG; Tacconelli, S | 1 |
| Koivisto, AM; Mäenpää, J; Riutta, A; Vainio, M | 1 |
| Hillbom, M; Juvela, S; Pyhtinen, J; Riutta, A; Saloheimo, P | 1 |
| Anzellotti, P; Capone, ML; Di Francesco, L; Di Gregorio, P; Merciaro, G; Patrignani, P; Sciulli, MG; Tacconelli, S | 1 |
| Barbieri, SS; Cavalca, V; Dragani, A; Pagliaccia, F; Patrono, C; Porro, B; Rocca, B; Squellerio, I; Tremoli, E; Veglia, F | 1 |
| Anand, SS; Chasman, DI; Connolly, SJ; Eikelboom, J; Eriksson, N; Gerstein, HC; Mehta, S; Paré, G; Ridker, PM; Rose, L; Ross, S; Wallentin, L; Yusuf, S | 1 |
10 trial(s) available for aspirin and 2,3-dinor-6-ketoprostaglandin f1alpha
| Article | Year |
|---|---|
Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Allergens; Aspirin; Blood Platelets; Bronchial Spasm; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Female; Forced Expiratory Volume; Gas Chromatography-Mass Spectrometry; Humans; Male; Placebos; Platelet Activation; Thromboxane A2; Thromboxane B2 | 1989 |
Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Humans; Infusions, Intravenous; Injections; Male; Prostaglandins; Thromboxane B2; Thromboxanes | 1989 |
Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Dinoprostone; Diuresis; Drug Interactions; Electrolytes; Humans; Platelet Aggregation; Prostaglandins; Prostaglandins E; Random Allocation; Salicylates; Thromboxane B2 | 1986 |
Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Dinoprostone; Epoprostenol; Exercise; Gas Chromatography-Mass Spectrometry; Humans; Male; Physical Endurance; Physical Fitness; Platelet Aggregation; Thromboxane B2 | 1995 |
Reduced fetal exposure to aspirin using a novel controlled-release preparation in normotensive and hypertensive pregnancies.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Cyclooxygenase Inhibitors; Delayed-Action Preparations; Double-Blind Method; Eicosanoids; Female; Fetal Blood; Humans; Pre-Eclampsia; Pregnancy; Thromboxane B2 | 1998 |
Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Epoprostenol; F2-Isoprostanes; Female; Humans; Isoenzymes; Macrophages; Male; Membrane Proteins; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Thromboxane A2; Thromboxane B2 | 2000 |
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Blood Platelets; Cardiotonic Agents; Cross-Over Studies; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Endothelial Cells; Endothelium, Vascular; Female; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Monocytes; Naproxen; Prostaglandin-Endoperoxide Synthases; Prostaglandins I; Thromboxane B2 | 2004 |
Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Hypertension, Pregnancy-Induced; Longitudinal Studies; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pregnancy, High-Risk; Prostaglandins; Thromboxane A2; Thromboxane B2 | 2004 |
Human pharmacology of naproxen sodium.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Humans; Lipopolysaccharides; Monocytes; Naproxen; Platelet Aggregation; Thromboxane B2 | 2007 |
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aspirin; Blood Platelets; Clinical Protocols; Drug Dosage Calculations; Epoprostenol; Female; Humans; Male; Middle Aged; Platelet Aggregation; Thrombocythemia, Essential; Thromboxane A2 | 2014 |
13 other study(ies) available for aspirin and 2,3-dinor-6-ketoprostaglandin f1alpha
| Article | Year |
|---|---|
Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aspirin; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Epoprostenol; Female; Humans; Male; Middle Aged; Platelet Aggregation; Thromboxane A2; Thromboxane B2 | 1992 |
Radioimmunoassay measurement of 2,3-dinor metabolites of prostacyclin and thromboxane in human urine.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Blood Platelets; Female; Humans; Kidney; Male; Radioimmunoassay; Sulindac; Thromboxane B2 | 1987 |
Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Epoprostenol; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Prostaglandin Antagonists; Thromboxane B2; Time Factors | 1986 |
Comparison of the effects of selective inhibition of thromboxane synthase with those of inhibition of the cyclooxygenase enzyme in man.
Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Imidazoles; Male; Oxidoreductases; Pyridines; Thromboxane-A Synthase; Time Factors | 1984 |
Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1 alpha and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Anti-Inflammatory Agents; Aspirin; Child; Child, Preschool; Female; Gas Chromatography-Mass Spectrometry; Humans; Indomethacin; Male; Middle Aged; Physical Exertion | 1984 |
Implications of the prognostic importance of exercise-induced thromboxane formation in survivors of an acute myocardial infarction.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic beta-Antagonists; Adult; Aged; Aspirin; Epoprostenol; Exercise; Exercise Test; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Thromboxane A2; Thromboxane B2 | 1995 |
Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Anemia, Sickle Cell; Aspirin; Blood Platelets; Female; Humans; Male; Phosphorylation; Prostaglandin Endoperoxides, Synthetic; Thrombin; Thromboxane A2; Thromboxane B2 | 1993 |
Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Cyclooxygenase Inhibitors; Embolism, Fat; Epoprostenol; Evaluation Studies as Topic; Hemodynamics; Hypertension, Pulmonary; Lung Diseases; Random Allocation; Swine; Thromboxane A2; Thromboxane B2 | 1997 |
Increased formation of thromboxane in vivo in humans with mastocytosis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Aspirin; beta-Thromboglobulin; Cyclooxygenase Inhibitors; Female; Humans; Male; Methylhistamines; Middle Aged; Platelet Factor 4; Prostaglandins D; Thromboxane B2; Urticaria Pigmentosa | 1999 |
Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aspirin; Dose-Response Relationship, Drug; Epoprostenol; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Pilot Projects; Prostaglandins F; Retinal Artery Occlusion; Retinal Vein Occlusion; Thromboxane A2; Thromboxane B2; Thromboxanes | 1999 |
Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Apoptosis; Arachidonic Acid; Aspirin; Biomarkers; Cardiomyopathies; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Doxorubicin; Enzyme Induction; Epoprostenol; Heart; Iloprost; Isoenzymes; L-Lactate Dehydrogenase; Male; Membrane Proteins; Myocardium; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Sulfonamides; Thromboxane B2; Transcription Factors; Troponin T | 2001 |
Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Aged; Aspirin; Bleeding Time; Blood Coagulation; Cerebral Hemorrhage; Epoprostenol; Female; Humans; Male; Middle Aged; Prospective Studies; Regression Analysis; Thromboxane A2; Thromboxane B2 | 2005 |
Association of cyclooxygenase-2 genetic variant with cardiovascular disease.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aspirin; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Female; Heterozygote; Humans; Male; Multicenter Studies as Topic; Myocardial Infarction; Polymorphism, Genetic; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Thromboxane B2 | 2014 |